Peters, Mary Linton B.
Tseng, Jennifer F.
Miksad, Rebecca A.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer
https://doi.org/10.1136/esmoopen-2019-000634
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Targeting the hallmarks of ovarian cancer: The big picture
https://doi.org/10.1016/j.ygyno.2016.03.037
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Current concepts and novel targets in advanced pancreatic cancer
https://doi.org/10.1136/gutjnl-2012-303588
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Advances in Hereditary Colorectal and Pancreatic Cancers
https://doi.org/10.1016/j.clinthera.2016.03.017
Current concepts and novel targets in advanced pancreatic cancer
https://doi.org/10.1136/gutjnl-2012-303588
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
A genetic roadmap of pancreatic cancer: still evolving
https://doi.org/10.1136/gutjnl-2016-313317
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Stromal biology and therapy in pancreatic cancer: a changing paradigm
https://doi.org/10.1136/gutjnl-2015-309304
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
https://doi.org/10.1136/jitc-2021-004434
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
https://doi.org/10.1136/jitc-2023-007440
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
https://doi.org/10.1136/gutjnl-2018-316451
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
https://doi.org/10.1136/jitc-2022-006624
Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures
https://doi.org/10.1136/jitc-2021-002345
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer
https://doi.org/10.1136/jitc-2022-006658
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density
https://doi.org/10.1007/s10549-021-06355-9
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Updated efficacy and safety of entrectinib in patients (pts) with locally advanced/metastatic <i>NTRK</i> fusion-positive (fp) non-small cell lung cancer (NSCLC).
https://doi.org/10.1200/jco.2023.41.16_suppl.9047
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Advances in Hereditary Colorectal and Pancreatic Cancers
https://doi.org/10.1016/j.clinthera.2016.03.017
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
https://doi.org/10.1200/jco.21.01604
A genetic roadmap of pancreatic cancer: still evolving
https://doi.org/10.1136/gutjnl-2016-313317
Documents that mention this clinical trial
Is the NCI MATCH trial a match for gynecologic oncology?
https://doi.org/10.1016/j.ygyno.2015.11.003
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer
https://doi.org/10.1136/esmoopen-2019-000634
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion
https://doi.org/10.1136/jitc-2024-010926
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Documents that mention this clinical trial
Updated efficacy and safety of entrectinib in patients (pts) with locally advanced/metastatic <i>NTRK</i> fusion-positive (fp) non-small cell lung cancer (NSCLC).
https://doi.org/10.1200/jco.2023.41.16_suppl.9047
Efficacy and safety of entrectinib in children with extracranial solid or primary central nervous system (CNS) tumors harboring <i>NTRK</i> or <i>ROS1</i> fusions.
https://doi.org/10.1200/jco.2024.42.16_suppl.10000
Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
https://doi.org/10.1016/j.clinthera.2016.03.006
Clinicopathological characterisation of <i>MTAP</i> alterations in gastrointestinal cancers
https://doi.org/10.1136/jcp-2023-209341
This article is maintained by: Elsevier
Article Title: Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment
Journal Title: Clinical Therapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinthera.2016.03.006
Content Type: article
Copyright: © 2016 Elsevier Inc. All rights reserved.